Efficacy of a Multicomponent Intervention for Fibromyalgia Based on Pain Neuroscience Education, Exercise Therapy, Psychological Support, and Nature Exposure (NAT-FM): Study Protocol of a Randomized Controlled Trial
Overview
Public Health
Authors
Affiliations
The study protocol of a prospective and randomized controlled trial for the assessment of the efficacy of nature activity therapy for people with Fibromyalgia (NAT-FM) is described. The primary outcome is the mean change from baseline in the Revised Fibromyalgia Impact Questionnaire (FIQR) score at post-treatment (12 weeks) and at 9 months of follow-up, and secondary outcomes are changes in the positive affect, negative affect, pain, fatigue, self-efficacy, catastrophising, and emotional regulation. A total of 160 patients with fibromyalgia will be divided into two arms: treatment-as-usual (TAU) and NAT-FM+TAU. Pre, during, post, +6, and +9 months assessments will be carried out, as well as an ecological momentary assessment (EMA) of intrasession and intersessions. Results will be subjected to a mixed group (NAT-FM+TAU vs. TAU) × phase (pre, post, +6 months, +9 months) general linear model. EMA intrasession measurements will be subjected to a 2 (pre vs. post) × 5 (type of activity) mixed-effects ANOVA. EMA between-session measurements obtained from both arms of the study will be analysed on both a time-domain and frequency-domain basis. Effect sizes and number needed to treat (NNT) will be computed. A mediation/moderation analysis will be conducted.
Martin-Borras C, Gonzalez Serra G, Carrasco-Querol N, Sansano-Nadal O, Bueno Hernandez N, Bestraten Del Pino P Front Physiol. 2024; 15:1441076.
PMID: 39717828 PMC: 11663864. DOI: 10.3389/fphys.2024.1441076.
Galvez-Sanchez C, Montoro C Behav Sci (Basel). 2023; 13(5).
PMID: 37232652 PMC: 10215575. DOI: 10.3390/bs13050415.
Geraghty A, Maund E, Newell D, Santer M, Everitt H, Price C PLoS One. 2021; 16(7):e0254642.
PMID: 34270606 PMC: 8284796. DOI: 10.1371/journal.pone.0254642.
Serrat M, Almirall M, Muste M, Sanabria-Mazo J, Feliu-Soler A, Mendez-Ulrich J J Clin Med. 2020; 9(10).
PMID: 33081069 PMC: 7603188. DOI: 10.3390/jcm9103348.
Sanabria-Mazo J, Montero-Marin J, Feliu-Soler A, Gasion V, Navarro-Gil M, Morillo-Sarto H J Clin Med. 2020; 9(10).
PMID: 33050630 PMC: 7599726. DOI: 10.3390/jcm9103246.